Commentary: COVID-19 and the Path to Immunity.
作者信息
James Lisa M, Tsilibary Effie-Photini C, Charonis Spyros, Georgopoulos Apostolos P
机构信息
Brain Sciences Center, Department of Veterans Affairs Health Care System, Minneapolis, MN, USA.
Department of Neuroscience, University of Minnesota Medical School, Minneapolis, MN, USA.
出版信息
J Immunol Sci. 2020 Nov 23;4(4):31-33. doi: 10.29245/2578-3009/2020/4.1201.
Abstract
摘要
相似文献
1
Commentary: COVID-19 and the Path to Immunity.评论：2019冠状病毒病与免疫之路
J Immunol Sci. 2020 Nov 23;4(4):31-33. doi: 10.29245/2578-3009/2020/4.1201.
2
Immunity's core reset: Synbiotics and gut microbiota in the COVID-19 era.免疫的核心重置：新冠疫情时代的合生元与肠道微生物群
Innate Immun. 2025 Jan-Dec;31:17534259251362023. doi: 10.1177/17534259251362023. Epub 2025 Jul 27.
3
Polio outbreaks in the post-COVID-19 pandemic era: causes and solutions.新冠疫情后时代的脊髓灰质炎疫情：成因与解决办法
Pathog Glob Health. 2025 Feb-Mar;119(1-2):60-72. doi: 10.1080/20477724.2024.2439740. Epub 2024 Dec 17.
4
Hybrid versus vaccine immunity of mRNA-1273 among people living with HIV in East and Southern Africa: a prospective cohort analysis from the multicentre CoVPN 3008 (Ubuntu) study.东非和南部非洲艾滋病毒感染者中mRNA-1273的混合免疫与疫苗免疫：多中心CoVPN 3008（Ubuntu）研究的前瞻性队列分析
EClinicalMedicine. 2025 Jan 20;80:103054. doi: 10.1016/j.eclinm.2024.103054. eCollection 2025 Feb.
5
Impact of nutraceuticals on immunomodulation against viral infections-A review during COVID-19 pandemic in Indian scenario.营养保健品对免疫调节抵抗病毒感染的影响——在印度 COVID-19 大流行背景下的综述。
J Biochem Mol Toxicol. 2023 May;37(5):e23320. doi: 10.1002/jbt.23320. Epub 2023 Feb 17.
6
The Second Round of a Population-Based Seroprevalence Study of Anti-SARS-CoV-2 Antibodies and COVID-19 Vaccination Assessment in the Republika Srpska, Bosnia and Herzegovina.波斯尼亚和黑塞哥维那斯普斯卡共和国第二轮基于人群的抗SARS-CoV-2抗体血清流行率研究及新冠疫苗接种评估
Influenza Other Respir Viruses. 2025 Jan;19(1):e70053. doi: 10.1111/irv.70053.
7
Hybrid and vaccination immunity against severe COVID-19 in the post-pandemic era-a retrospective cohort study.大流行后时代混合免疫和疫苗接种免疫对重症 COVID-19 的影响——一项回顾性队列研究
Clin Microbiol Infect. 2025 Aug;31(8):1371-1377. doi: 10.1016/j.cmi.2025.05.002. Epub 2025 May 9.
8
Surfing Corona waves - instead of breaking them: Rethinking the role of natural immunity in COVID-19 policy.冲浪科罗娜波浪 - 而不是打破它们：重新思考自然免疫在 COVID-19 政策中的作用。
F1000Res. 2023 Aug 24;11:337. doi: 10.12688/f1000research.110593.2. eCollection 2022.
9
COVID-19 infection in inborn errors of immunity and their phenocopies: a systematic review and meta-analysis.先天性免疫缺陷及其表型模拟中的新型冠状病毒肺炎感染：一项系统评价和荟萃分析。
Infect Dis (Lond). 2025 Jun;57(6):483-517. doi: 10.1080/23744235.2025.2483339. Epub 2025 Apr 3.
10
A 20-month longitudinal study to evaluate humoral and cellular immunity after COVID-19 vaccines.一项评估新冠疫苗接种后体液免疫和细胞免疫的20个月纵向研究。
Mem Inst Oswaldo Cruz. 2025 Jul 18;120:e240193. doi: 10.1590/0074-02760240193. eCollection 2025.
本文引用的文献
1
Anthrax and Gulf War Illness (GWI): Evidence for the Presence of Harmful Anthrax Antigen PA63 In the Serum of Veterans with GWI.炭疽与海湾战争综合征（GWI）：海湾战争综合征退伍军人血清中存在有害炭疽抗原PA63的证据。
J Neurol Neuromedicine. 2019 Nov 25;4(6):1-9. doi: 10.29245/2572.942x/2019/6.1255.
2
Persistent Antigens Hypothesis: The Human Leukocyte Antigen (HLA) Connection.持续性抗原假说：人类白细胞抗原（HLA）关联
J Neurol Neuromedicine. 2018 Dec 24;3(6):27-1. doi: 10.29245/2572.942x/2018/6.1235.
3
SARS-CoV-2 Virus and Human Leukocyte Antigen (HLA) Class II: Investigation in silico of Binding Affinities for COVID-19 Protection and Vaccine Development.严重急性呼吸综合征冠状病毒2（SARS-CoV-2）与人类白细胞抗原（HLA）II类：针对新冠病毒疾病（COVID-19）防护和疫苗开发的结合亲和力的计算机模拟研究
J Immunol Sci. 2020 Nov 16;4(4):12-23. doi: 10.29245/2578-3009/2020/4.1198.
4
As Their Numbers Grow, COVID-19 "Long Haulers" Stump Experts.随着新冠“长期症状者”数量的增加，专家们也感到困惑。
JAMA. 2020 Oct 13;324(14):1381-1383. doi: 10.1001/jama.2020.17709.
5
Correlation of the two most frequent HLA haplotypes in the Italian population to the differential regional incidence of Covid-19.意大利人群中两种最常见 HLA 单倍型与新冠病毒在不同地区发病率差异的相关性。
J Transl Med. 2020 Sep 15;18(1):352. doi: 10.1186/s12967-020-02515-5.
6
COVID-19 and the Path to Immunity.新冠病毒肺炎与免疫之路
JAMA. 2020 Oct 6;324(13):1279-1281. doi: 10.1001/jama.2020.16656.
7
Symptom Duration and Risk Factors for Delayed Return to Usual Health Among Outpatients with COVID-19 in a Multistate Health Care Systems Network - United States, March-June 2020.症状持续时间和多州医疗保健系统网络中 COVID-19 门诊患者恢复健康延迟的风险因素 - 美国，2020 年 3 月至 6 月。
MMWR Morb Mortal Wkly Rep. 2020 Jul 31;69(30):993-998. doi: 10.15585/mmwr.mm6930e1.
8
Persistent Symptoms in Patients After Acute COVID-19.急性 COVID-19 后患者的持续症状。
JAMA. 2020 Aug 11;324(6):603-605. doi: 10.1001/jama.2020.12603.
9
COVID-19 cardiac injury: Implications for long-term surveillance and outcomes in survivors.COVID-19 相关心脏损伤：对幸存者长期监测和结局的影响。
Heart Rhythm. 2020 Nov;17(11):1984-1990. doi: 10.1016/j.hrthm.2020.06.026. Epub 2020 Jun 26.
10
The trinity of COVID-19: immunity, inflammation and intervention.COVID-19 的三位一体：免疫、炎症和干预。
Nat Rev Immunol. 2020 Jun;20(6):363-374. doi: 10.1038/s41577-020-0311-8. Epub 2020 Apr 28.
Zotero 插件